Daphne Koller, founder and CEO at insitro and AI expert, discusses the use of AI in life sciences, including the POSH approach for potential therapeutic interventions. They also explore the power of AI in analyzing cellular images and clinical data, and the challenges of merging biology and ML AI.
Advancements in technology enable the collection and analysis of large-scale biological data, unlocking the potential of machine learning in life sciences.
Leveraging AI and biological tools can accelerate drug discovery, leading to effective medicines and addressing various medical conditions.
Deep dives
The Power of AI in Life Sciences
Daphne emphasizes the significant impact that AI can have in the field of life sciences. She discusses how advancements in technology have enabled the collection and analysis of large-scale biological data, allowing for more meaningful deployment of machine learning methods. Daphne also highlights the importance of bridging the gap between machine learning and biomedical disciplines to leverage the full potential of AI in life sciences.
Using AI to Unlock Biological Insights
Daphne explains how her company, InCITRO, leverages AI to generate and analyze vast amounts of cellular and clinical data. By utilizing pluripotent stem cells and CRISPR technology, they can create cell models with diverse genetic mutations, allowing them to study the effects of these mutations and identify potential therapeutic targets. The ability to generate and manipulate their own data sets enables both important discoveries and interesting machine learning applications in the field of life sciences.
The Future of AI-based Drug Discovery
Daphne envisions a future where AI plays a crucial role in drug discovery and development. She emphasizes the need to build a systematic process that combines AI and biology to efficiently identify meaningful interventions for specific diseases. Daphne believes that by leveraging AI and continuously improving biological tools, they can accelerate the development of effective medicines and address a wide range of medical conditions. This convergence of AI and life sciences presents an unprecedented opportunity to make a significant impact on healthcare, agriculture, and the environment.
This episode is live from our recent AI Revolutionaries (AIR) conference. In this episode, Daphne Koller, founder and CEO at insitro and AI expert, chats with Vijay Pande of Bio + Health.
You can check out the full conversation with video and transcript at https://a16z.com/digital-biology/.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode